99 related articles for article (PubMed ID: 1758890)
1. Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate.
Dugué J; Céolin R; Rouland JC; Lepage F
Pharm Acta Helv; 1991; 66(11):307-10. PubMed ID: 1758890
[TBL] [Abstract][Full Text] [Related]
2. Crystallization of carbamazepine pseudopolymorphs from nonionic microemulsions.
Kogan A; Popov I; Uvarov V; Cohen S; Aserin A; Garti N
Langmuir; 2008 Feb; 24(3):722-33. PubMed ID: 18163657
[TBL] [Abstract][Full Text] [Related]
3. Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate.
Han J; Suryanarayanan R
Pharm Dev Technol; 1998 Nov; 3(4):587-96. PubMed ID: 9834963
[TBL] [Abstract][Full Text] [Related]
4. Unintended water mediated cocrystal formation in carbamazepine and aspirin tablets.
Arora KK; Tayade NG; Suryanarayanan R
Mol Pharm; 2011 Jun; 8(3):982-9. PubMed ID: 21548636
[TBL] [Abstract][Full Text] [Related]
5. In situ dehydration of carbamazepine dihydrate: a novel technique to prepare amorphous anhydrous carbamazepine.
Li Y; Han J; Zhang GG; Grant DJ; Suryanarayanan R
Pharm Dev Technol; 2000; 5(2):257-66. PubMed ID: 10810755
[TBL] [Abstract][Full Text] [Related]
6. Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms.
Censi R; Rascioni R; Di Martino P
Eur J Pharm Biopharm; 2015 May; 92():192-203. PubMed ID: 25796350
[TBL] [Abstract][Full Text] [Related]
7. Solubility and stability of anhydrate/hydrate in solvent mixtures.
Qu H; Louhi-Kultanen M; Kallas J
Int J Pharm; 2006 Sep; 321(1-2):101-7. PubMed ID: 16784825
[TBL] [Abstract][Full Text] [Related]
8. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.
Rodríguez-Hornedo N; Murphy D
J Pharm Sci; 2004 Feb; 93(2):449-60. PubMed ID: 14705201
[TBL] [Abstract][Full Text] [Related]
9. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder.
Murphy D; Rodríguez-Cintrón F; Langevin B; Kelly RC; Rodríguez-Hornedo N
Int J Pharm; 2002 Oct; 246(1-2):121-34. PubMed ID: 12270615
[TBL] [Abstract][Full Text] [Related]
10. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.
Tian F; Zhang F; Sandler N; Gordon KC; McGoverin CM; Strachan CJ; Saville DJ; Rades T
Eur J Pharm Biopharm; 2007 Jun; 66(3):466-74. PubMed ID: 17257816
[TBL] [Abstract][Full Text] [Related]
11. De- and rehydration behavior of alpha,alpha-trehalose dihydrate under humidity-controlled atmospheres.
Furuki T; Kishi A; Sakurai M
Carbohydr Res; 2005 Feb; 340(3):429-38. PubMed ID: 15680598
[TBL] [Abstract][Full Text] [Related]
12. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
13. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
[TBL] [Abstract][Full Text] [Related]
14. Solid state dehydration processes: mechanism of water loss from crystalline inosine dihydrate.
Gillon AL; Davey RJ; Storey R; Feeder N; Nichols G; Dent G; Apperley DC
J Phys Chem B; 2005 Mar; 109(11):5341-7. PubMed ID: 16863200
[TBL] [Abstract][Full Text] [Related]
15. One-solvent polymorph screen of carbamazepine.
Getsoian A; Lodaya RM; Blackburn AC
Int J Pharm; 2008 Feb; 348(1-2):3-9. PubMed ID: 17945448
[TBL] [Abstract][Full Text] [Related]
16. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
17. Characterization of dihydrates prepared from carbamazepine polymorphs.
McMahon LE; Timmins P; Williams AC; York P
J Pharm Sci; 1996 Oct; 85(10):1064-9. PubMed ID: 8897272
[TBL] [Abstract][Full Text] [Related]
18. Effects of dehydration temperature on water vapor adsorption and dissolution behavior of carbamazepine.
Ono M; Tozuka Y; Oguchi T; Yamamura S; Yamamoto K
Int J Pharm; 2002 Jun; 239(1-2):1-12. PubMed ID: 12052686
[TBL] [Abstract][Full Text] [Related]
19. Anti-solvent co-crystallization of carbamazepine and saccharin.
Wang IC; Lee MJ; Sim SJ; Kim WS; Chun NH; Choi GJ
Int J Pharm; 2013 Jun; 450(1-2):311-22. PubMed ID: 23598078
[TBL] [Abstract][Full Text] [Related]
20. Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.
Sathisaran I; Dalvi SV
AAPS PharmSciTech; 2021 Jan; 22(1):29. PubMed ID: 33404968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
